Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Submitted by
admin
on March 14, 2014 - 8:39am
Source:
Motley Fool
News Tags:
biotech
Sarepta Therapeutics
OncoMed
Vivus
MannKind
Myriad Genetics
Headline:
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Do Not Allow Advertisers to Use My Personal information
